QA: Esperion Therapeutics Inc in us_pharma/2013

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001434868_2014_Esperion_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0001434868, Esperion Therapeutics Inc

  xvar xval
0 AssetsCurrent 60,619,649
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 80,808
3 remainder_Assets 17,593,403
4 LiabilitiesCurrent 4,202,491
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 6,744,493
9 ResearchAndDevelopmentExpense 16,099,817
10 remainder_Expenses 3,437,833
11 remainder_Revenues 0
12 remainder_NetIncome 438,489
13 remainder_ComprehensiveNetIncome -3,034
  yvar yval
0 Assets 78,293,860
1 Liabilities 4,202,491
2 Expenses 26,282,143
3 Revenues 0
4 StockholdersEquity 74,091,369
5 NetIncome -25,843,654
6 ComprehensiveNetIncome -25,845,171
7 BaseVar 54,610,008
8 EconomicCapitalRatiobeforeLimitedLiability 3.29
9 EconomicCapitalRatio 3.88

Edgar->Model Mapping

Feature Distribution